Display Settings:

Format

Send to:

Choose Destination

    Arch Pediatr. 2007 Nov;14(11):1350-5. Epub 2007 Aug 15.

    [Treatment of airway inflammation in cystic fibrosis]

    [Article in French]

    Abély M.

    Service de pédiatrie A, centre de ressources et de compétences pour la mucoviscidose, American Memorial Hospital, CHU de Reims, 47, rue Cognacq-Jay, 51092 Reims cedex, France. mabely@chu-reims.fr

    Cystic fibrosis airway inflammation is characterized by neutrophilic efflux and high levels of proinflammatory cytokines such as IL-8 and IL-6. Inhaled corticosteroids are widely used despite lack of evidence of efficacity. Despite evidence of efficacity of ibuprofen, many clinicians have chosen not to use this therapy because of concerns regarding potential side effects. Azithromycin has antiinflammatory properties and is effective in cystic fibrosis (CF) patients. Deoxyribonuclease (rhDNase) has been shown to improve lung function in patients with cystic fibrosis and may also have a positive effect on inflammation. Other antiinflammatory drugs are in the process of validation.

    PMID: 17702549 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information